Anavex Life Sciences Corp. (AVXL)
2.535
-0.08
(-3.24%)
USD |
NASDAQ |
Jun 09, 16:00
2.535
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Total Assets (Quarterly) : 132.99M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Tenaya Therapeutics, Inc. | 135.07M |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Oncolytics Biotech, Inc. | 8.161M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.179B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.371M |
| Shareholders Equity (Quarterly) | 126.62M |
| Current Ratio | 20.87 |